237 related articles for article (PubMed ID: 26928949)
41. Obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Nemani KV; Trask HW; Ringelberg CS; Gimi B; Demidenko E; Tomlinson CR
Nutr Res; 2017 Aug; 44():38-50. PubMed ID: 28821316
[TBL] [Abstract][Full Text] [Related]
42. Up-regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy.
Bai M; Chen M; Zeng Q; Lu S; Li P; Ma Z; Lin N; Zheng C; Zhou H; Zeng S; Sun D; Jiang H
Br J Pharmacol; 2022 Sep; 179(17):4440-4456. PubMed ID: 35491243
[TBL] [Abstract][Full Text] [Related]
43. Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner.
Yan Y; Wu X; Wang P; Zhang S; Sun L; Zhao Y; Zeng G; Liu B; Xu G; Liu H; Wang L; Wang X; Jiang C
Redox Biol; 2020 Oct; 37():101742. PubMed ID: 33045621
[TBL] [Abstract][Full Text] [Related]
44. Pregnane X receptor regulates the AhR/Cyp1A1 pathway and protects liver cells from benzo-[α]-pyrene-induced DNA damage.
Cui H; Gu X; Chen J; Xie Y; Ke S; Wu J; Golovko A; Morpurgo B; Yan C; Phillips TD; Xie W; Luo J; Zhou Z; Tian Y
Toxicol Lett; 2017 Jun; 275():67-76. PubMed ID: 28428138
[TBL] [Abstract][Full Text] [Related]
45. Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis.
Gwag T; Meng Z; Sui Y; Helsley RN; Park SH; Wang S; Greenberg RN; Zhou C
J Hepatol; 2019 May; 70(5):930-940. PubMed ID: 30677459
[TBL] [Abstract][Full Text] [Related]
46. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces liver lipid metabolism disorder via the ROS/AMPK/CD36 signaling pathway.
Cong Y; Hong Y; Wang D; Cheng P; Wang Z; Xing C; Sun W; Xu G
Toxicol Sci; 2023 Feb; 191(2):276-284. PubMed ID: 36534932
[TBL] [Abstract][Full Text] [Related]
47. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.
Werstuck GH; Lentz SR; Dayal S; Hossain GS; Sood SK; Shi YY; Zhou J; Maeda N; Krisans SK; Malinow MR; Austin RC
J Clin Invest; 2001 May; 107(10):1263-73. PubMed ID: 11375416
[TBL] [Abstract][Full Text] [Related]
48. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.
Cheng Z; Jiang X; Pansuria M; Fang P; Mai J; Mallilankaraman K; Gandhirajan RK; Eguchi S; Scalia R; Madesh M; Yang X; Wang H
Diabetes; 2015 Mar; 64(3):947-59. PubMed ID: 25352635
[TBL] [Abstract][Full Text] [Related]
49. PKM2-dependent metabolic reprogramming in CD4
Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J
J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501
[TBL] [Abstract][Full Text] [Related]
50. Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.
Choi YJ; Lee CH; Lee KY; Jung SH; Lee BH
Toxicol Sci; 2015 Jun; 145(2):273-82. PubMed ID: 25745068
[TBL] [Abstract][Full Text] [Related]
51. The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease.
He J; Lee JH; Febbraio M; Xie W
Exp Biol Med (Maywood); 2011 Oct; 236(10):1116-21. PubMed ID: 21885479
[TBL] [Abstract][Full Text] [Related]
52. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
[TBL] [Abstract][Full Text] [Related]
53. Aryl hydrocarbon receptor-ligand axis mediates pulmonary fibroblast migration and differentiation through increased arachidonic acid metabolism.
Su HH; Lin HT; Suen JL; Sheu CC; Yokoyama KK; Huang SK; Cheng CM
Toxicology; 2016 Aug; 370():116-126. PubMed ID: 27697457
[TBL] [Abstract][Full Text] [Related]
54. Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease.
Patil NY; Rus I; Downing E; Mandala A; Friedman JE; Joshi AD
J Pharmacol Exp Ther; 2022 Oct; 383(1):32-43. PubMed ID: 35933113
[TBL] [Abstract][Full Text] [Related]
55. [KLF9 regulates hepatic lipid metabolism via inducing CD36 expression].
Zhou SS; Zhang YL; Chang YS
Sheng Li Xue Bao; 2021 Oct; 73(5):772-780. PubMed ID: 34708234
[TBL] [Abstract][Full Text] [Related]
56. Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway.
Yu H; Yang F; Zhong W; Jiang X; Zhang F; Ji X; Xue M; Qiu Y; Yu J; Hu X; Chen J; Bao Z
Cell Signal; 2021 Aug; 84():110043. PubMed ID: 33991615
[TBL] [Abstract][Full Text] [Related]
57. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ.
Chen J; Wang W; Qi Y; Kaczorowski D; McCaughan GW; Gamble JR; Don AS; Gao X; Vadas MA; Xia P
Biochim Biophys Acta; 2016 Feb; 1861(2):138-147. PubMed ID: 26615875
[TBL] [Abstract][Full Text] [Related]
58. Homocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes.
Luo X; Xiao L; Yang H; Zhang R; Jiang M; Ni J; Lei T; Wang N
Nutr Metab (Lond); 2014; 11(1):55. PubMed ID: 25520741
[TBL] [Abstract][Full Text] [Related]
59. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
[TBL] [Abstract][Full Text] [Related]
60. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.
Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ
Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
